Amy Coxon
- Oncology top 2%
- Cancer-related Molecular Pathways 9
- Peptidase Inhibition and Analysis 3
- Ophthalmology top 5%
- Ocular Oncology and Treatments 5
- Oral Surgery top 5%
- Cancer Research top 10%
- Molecular Biology top 10%
- Cancer-related gene regulation 4
- Genomics and Chromatin Dynamics 2
-
- Virus-based gene therapy research 2
-
- Neuroendocrine Tumor Research Advances 2
-
- Salivary Gland Tumors Diagnosis and Treatment 2
- Co-authors
- Frederic J. KayeGregory A. OttersonRobert A. KratzkeSamir N. KhleifTakefumi KomiyaIlan R. KirschAkihito KuboKevin O’Neil
- Cited by
- OncologyOphthalmologyOral Surgery
- Partner nations
- United StatesUkraineMalaysia
In The Last Decade
Amy Coxon
20 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 74
- Oncology 1.0k
- Ophthalmology 152
- Oral Surgery 116
- Cancer Research 199
- Molecular Biology 851
Countries citing papers authored by Amy Coxon
This map shows the geographic impact of Amy Coxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Coxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Coxon more than expected).
Fields of papers citing papers by Amy Coxon
This network shows the impact of papers produced by Amy Coxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Coxon. The network helps show where Amy Coxon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Coxon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 34 | |
| 2 | 2009 | 39 | |
| 3 | 2008 | 5 | |
| 4 | 2006 | 62 | |
| 5 | 2006 | 8 | |
| 6 | 2005 | 107 | |
| 7 | 2003 | 428 | |
| 8 | Euthanasia and Physician-Assisted Suicide: For and Against | 2001 | 1 |
| 9 | 2000 | 38 | |
| 10 | 1999 | 29 | |
| 11 | 1998 | 34 | |
| 12 | 1997 | 69 | |
| 13 | 1997 | 77 | |
| 14 | CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. | 1995 | 182 |
| 15 | 1995 | 278 | |
| 16 | 1995 | 98 | |
| 17 | 1994 | 41 | |
| 18 | Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. | 1994 | 51 |
| 19 | 1994 | 46 | |
| 20 | 1994 | 3 |
About Amy Coxon
Amy Coxon is a scholar working on Ophthalmology, Oncology and Cancer Research, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Ocular Oncology and Treatments (5 papers), Cancer-related gene regulation (4 papers), Peptidase Inhibition and Analysis (3 papers), Virus-based gene therapy research (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Oncology (1.0k citations), Ophthalmology (152 citations) and Oral Surgery (116 citations). Amy Coxon has collaborated with scholars based in United States, Ukraine and Malaysia. Frequent co-authors include Frederic J. Kaye, Gregory A. Otterson, Robert A. Kratzke, Samir N. Khleif, Takefumi Komiya, Ilan R. Kirsch, Akihito Kubo, Kevin O’Neil, Wei Chen and Giovanni Tonon. Their work appears in journals such as Oncogene, Lung Cancer, Molecular and Cellular Biology, Nature Genetics and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.